Latest Breaking News On - Free sample copy of research - Page 2 : comparemela.com

Search jobs Pneumonia Therapeutics Market: Upcoming Trends, Research Developments and Analysis Report to 2026 Pneumonia is a severe inflammation of the lungs. It can be fatal in some people, particularly the elderly and those with respiratory disorders. COVID-19, a disease caused by a novel coronavirus, can spread to the lungs, causing pneumonia. The disease associated with the new coronavirus was originally referred to as novel coronavirus-infected pneumonia (NCIP). It was renamed COVID-19 by the World Health Organization, short for coronavirus disease in 2019. The ongoing COVID-19 pandemic has a positive impact on the demand patterns in the pneumonia therapeutics industry. According to the research report, the global pneumonia therapeutics market in 2019 was approximately USD 14.99 Billion. The market is expected to grow at a CAGR of 8.00% and is anticipated to reach around USD 25.67 Billion by 2026.

United statesAsia pacificBayer agLupin pharmaceuticals incFree sample copy of researchWorld health organizationMerck co incPfizer incFree sample copyResearch reportNorth americaLatin americaMiddle eastLupin pharmaceuticalsMore informationஒன்றுபட்டது மாநிலங்களில்